|
|
|
Volumn 48, Issue 1243, 2006, Pages 76-
|
|
Natalizumab (Tysabri) returns.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
BETA INTERFERON;
MONOCLONAL ANTIBODY;
NATALIZUMAB;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CROHN DISEASE;
DRUG COMBINATION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LEGAL ASPECT;
LEUKOENCEPHALOPATHY;
METHODOLOGY;
MULTIPLE SCLEROSIS;
NOTE;
POSTMARKETING SURVEILLANCE;
STANDARD;
TIME;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
AZATHIOPRINE;
CLINICAL TRIALS;
CROHN DISEASE;
DRUG THERAPY, COMBINATION;
HUMANS;
INTERFERON-BETA;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
MULTIPLE SCLEROSIS;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
PRODUCT SURVEILLANCE, POSTMARKETING;
TIME FACTORS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 33750117803
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|